Pain · 1989 · 237 citations · 30 references
MedicineAnesthesiologyPharmacologyAnesthesiaLocal AnesthesiaPain MedicineAnalgesiaAnalgesic PharmacologyAnesthetic PharmacologyLocal AnestheticsPain PhysiologySpinal AnesthesiaAnesthetic Effects On Nerve SignalsConductionFibersIntravenous LidocaineMechanical StimulationPain PharmacologyPharmacodynamics Of Local AnestheticsPharmacological Pain Relief
The study examined the effects of subanesthetic intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers in 7‑day‑old rat sciatic neuromas. All three drugs markedly suppressed SAF firing and mechanical sensitivity without causing conduction block, suggesting their analgesic effect may stem from reduced firing rates.
The effects of intravenously administered subanesthetic concentrations of lidocaine, tocainide, and mexiletine on spontaneously active fibers (SAFs) originating in 7-day-old rat sciatic neuromas were studied. Control injections of normal saline caused no decrease in SAF or discharge rate. Lidocaine and tocainide given in incremental doses of 5, 10, 15, 20 and up to 25 mg/kg caused nearly all observed SAFs to stop firing. Mexiletine given in doses of 3, 5, 7, 10 and up to 15 mg/kg showed similar results at lower doses. All agents decreased the sensitivity of SAF to mechanical stimulation. No conduction blockade occurred at these doses of intravenously administered local anesthetics. The demonstrated reduction in firing rate of SAF may explain the pain relief observed in clinical trials of these orally available agents.
30
MEXILETINE FOR TREATMENT OF CHRONIC PAINFUL DIABETIC NEUROPATHY
Anders Dejgård, Palle Petersen, Jens Kastrup · The Lancet · 1988 · 533 citations